Tensions in Mental Health Care in China: An Interview with Zhiying Ma
Anthropologist Zhiying Ma explores mental health care in China, including tensions between Western psychiatry and socially-oriented local frameworks.
Addressing the Roots of Racial Trauma: An Interview with Psychologist Lillian Comas-Díaz
MIA’s Hannah Emerson interviews Comas-Díaz on the need for culturally competent care in a medicalized and individualistic society.
Toward a Critical Self-Reflective Psychiatry: An Interview with Pat Bracken
MIA’s Justin Karter interviews critical psychiatrist and philosopher Pat Bracken about the necessity of challenging received wisdom.
Learning a Different Way: An Interview with Maori Psychiatrist Diana Kopua
MIA’s Ayurdhi Dhar interviews Diana Kopua about the Mahi a Atua approach, the global mental health movement, and the importance of language and narratives in how we understand our world and ease our suffering.
The Creation of a Conceptual Alternative to the DSM: An Interview with Dr. Lucy...
MIA's Zenobia Morrill interviews Lucy Johnstone about the reaction to the Power Threat Meaning Framework, her life influences, and her hopes for the future.
Bipartisan “RISE from Trauma Act” Introduced to Address Childhood Trauma in America
The Resilience Investment, Support, and Expansion (RISE) From Trauma Act, legislation designed to increase support for children who have been exposed to Adverse Childhood Experiences, includes $50 million in funding for a “mental health in schools” program. Exactly what these programs would entail remains unclear.
Getting Pharma Out of Medical Education: An Interview with Dr. Adriane Fugh-Berman
MIA's Gavin Crowell-Williamson interviews PharmedOut founder Dr. Adriane Fugh-Berman about Big Pharma's influence on medical education.
Mad Science, Psychiatric Coercion and the Therapeutic State: An Interview with Dr. David Cohen
MIA's Peter Simons interviews David Cohen, PhD, on his path to researching mental health, coercive practices, and discontinuation from psychiatric drugs.
Fighting for the Meaning of Madness: An Interview with Dr. John Read
Akansha Vaswani interviews Dr. John Read about the influences on his work and his research on madness, psychosis, and the mental health industry.
The New Yorker Peers into the Psychiatric Abyss… And Loses Its Nerve
The New Yorker's story on Laura Delano and psychiatric drug withdrawal is a glass-half-full story: It addresses a problem in psychiatry and yet hides the deeper story to be told. A story of how her recovery resulted from seeing herself within a counter-narrative that tells of the harm that psychiatry can do.
Constructing Alternatives to the DSM: An Interview with Dr. Jonathan Raskin
Dr. Raskin discusses psychotherapists’ dissatisfaction with current psychiatric diagnostic systems and explores alternatives.
The Effects of Antidepressant Exposure Across Generations: An Interview with Dr. Vance Trudeau
Dr. Vance Trudeau discusses his study's finding that antidepressants may have far-reaching, adverse effects that last up to three generations.
Peer-Support Groups Were Right, Guidelines Were Wrong: Dr. Mark Horowitz on Tapering Off Antidepressants
In an interview with MIA, Dr. Horowitz discusses his recent article on why tapering off antidepressants can take months or even years.
First-Person Accounts of Madness and Global Mental Health: An Interview with Dr. Gail Hornstein
Dr. Gail Hornstein, author of Agnes’s Jacket: A Psychologist’s Search for the Meanings of Madness, discusses the importance of personal narratives and service-user activism in the context of the global mental health movement.
Adolescent Suicide and The Black Box Warning: STAT Gets It All Wrong
STAT recently published an opinion piece arguing that the black box warning on antidepressants has led to an increase in adolescent suicide.
It is easily debunked, and reveals once again how our society is regularly misled about research findings related to psychiatric drugs. STAT has lent its good name to a false story that, unfortunately, will resonate loudly with the public.
Brain Implants: Spinning the Trial Results to Protect the Product
The published report of the Broaden Trial of Deep Brain Stimulation for Depression whitewashed the results: although the efficacy results were negative, the investigators concluded that the therapy still showed "promise", and adverse events suffered by the patients were downplayed or attributed to the disease, and not the treatment. An in-depth investigation of how the trial results were spun, and interviews with patients that tell of harm done.
Exploring Psychiatry’s “Black Hole”: The International Institute on Psychiatric Drug Withdrawal
When Carina Håkansson sent out an invitation for a symposium on "Pharmaceuticals: Risks and Alternatives," some of the world's top scientists, along with experts-by-experience, came from 13 countries to explore better ways to respond to people in crisis.
